US Stock MarketDetailed Quotes
SEELQ Seelos Therapeutics
- 0.299
- -0.059-16.50%
15min DelayClose Jan 6 16:00 ET
173.86KMarket Cap0.00P/E (TTM)
0.358High0.200Low8.47KVolume0.358Open0.358Pre Close2.77KTurnover1.46%Turnover Ratio0.00P/E (Static)581.00KShares0.75052wk High-0.01P/B173.23KFloat Cap0.17052wk Low--Dividend TTM578.86KShs Float0.750Historical High--Div YieldTTM44.20%Amplitude0.170Historical Low0.327Avg Price1Lot Size
About Seelos Therapeutics Company
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Company Profile
SymbolSEELQ
Company NameSeelos Therapeutics
Listing DateApr 26, 2000
Founded1987
CEODr. Raj Mehra, PhD
MarketPink Market
Employees16
Fiscal Year Ends12-31
Address300 Park Avenue,2nd Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10022
Phone1-646-293-2100
Company Executives
- Name
- Position
- Salary
- Dr. Raj Mehra, PhD
- Director, Chief Executive Officer and President
- 1.73M
- Michael Golembiewski
- Chief Financial Officer and Principal Accounting Officer
- 846.67K
- Richard W. Pascoe
- Chairman of the Board
- 87.72K
- Dr. Margaret Dalesandro, PhD
- Independent Director
- 89.72K
- Dr. Brian Lian, PhD
- Independent Director
- 105.22K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
